Journal of Pediatric Hematology/Oncology · 2017 · 19 citations · 29 references
MedicineOncologyPharmacotherapyChemotherapyPediatric Clinical PharmacologyPediatric OncologyAnthracycline CardiotoxicityCancer Therapy-related CardiotoxicityCardiotoxicity ManagementChemotherapy Toxicity ManagementPediatric ChemotherapyPediatric LeukemiasAcute Myeloid Leukemia TherapyAnthracycline-based ChemotherapyAnthracycline-induced CardiomyopathyAnthracycline-induced CardiotoxicityDexrazoxane ProphylaxisLate MortalityPediatric Anthracycline CardiotoxicityPediatric Cancer Cardiotoxicity
Anthracycline-induced cardiotoxicity remains a significant contributor to late morbidity/mortality in children and young adults with acute myeloid leukemia (AML). The cardioprotectant dexrazoxane can be used as prophylaxis to diminish risk for cardiomyopathy but whether it affects risk of relapse in pediatric AML is unclear. Our institution adopted the use of dexrazoxane before anthracyclines administration for all oncology patients in 2011. We compared patients with AML (ages, 0 to 21 y) who received or did not receive dexrazoxane during the years 2008 to 2013. In total, 44 patients with AML (ages, 4.5 mo to 21.7 y) were included. We identified no statistical difference in 2-year event rate (62% vs. 50%, P=0.41) or 2-year overall survival (69% vs. 69%, P=0.53) between patients receiving (n=28) or not receiving (n=16) dexrazoxane. Ejection fraction (P=0.0262) and shortening fraction (P=0.0381) trended significantly higher in patients that received dexrazoxane compared with those that did not receive dexrazoxane. Utilization of the cardioprotectant dexrazoxane before anthracycline chemotherapy in pediatric patients with AML demonstrated no significant difference in either event rate or overall survival relative to institutional controls and seems to improve cardiac function indices. Further studies in this patient population are needed to confirm these findings.
29
Chronic Health Conditions in Adult Survivors of Childhood Cancer
Kevin C. Oeffinger, Ann Mertens, Charles A. Sklar et al. · New England Journal of Medicine · 2006 · 3.6K citations
Trends in childhood cancer incidence in the U.S. (1992–2004)
Amy M. Linabery, Julie A. Ross · Cancer · 2007 · 648 citations
Medicine, Oncology, Pediatrics +17
Steven E. Lipshultz, M. Jacob Adams, Steven D. Colan et al. · Circulation · 2013 · 614 citations
Medicine, Oncology, Pediatrics +14